Hexal

Could This 1 Lawsuit Destroy Biogen Idec Stock?
Motley Fool
Tue, 07/22/14 - 05:08 pm
BiogenIdec
Tecfidera
MS
multiple sclerosis
patents
Actavis
Mylan
Synthon Pharmaceuticals
Novartis
Hexal
Sanofi
Zentiva